Thrombin-mediated proteoglycan synthesis utilizes both protein-tyrosine kinase and serine/threonine kinase receptor

Micah L Burch1, Robel Getachew, Narin Osman

  • 1Diabetes Complications Laboratory, Royal Melbourne Institute of Technology University, Bundoora, Victoria 3004, Australia.

Insights

Thrombin stimulates vascular smooth muscle cells to synthesize proteoglycans, a key factor in atherosclerosis plaque development. This study reveals novel signaling pathways involved in this process, offering potential therapeutic targets.

Area of Science:

  • Cellular signaling pathways
  • Vascular biology
  • Atherosclerosis research

Background:

  • G protein-coupled receptors (GPCRs) signal through classical pathways, β-arrestin scaffolding, and transactivation of receptor tyrosine kinases (e.g., EGF, PDGF).
  • GPCRs can also activate serine/threonine kinase receptors, including the transforming growth factor-β receptor family.
  • Atherosclerosis involves lipid-laden plaque formation in blood vessels, initiated by low-density lipoprotein retention mediated by proteoglycans.

Purpose of the Study:

  • To elucidate the mechanisms by which GPCRs, specifically thrombin signaling, stimulate proteoglycan synthesis in vascular smooth muscle cells.
  • To investigate the distinct pathways involved in protein-tyrosine kinase and serine/threonine kinase receptor transactivation.
  • To establish a link between these signaling pathways and the development of atherosclerotic plaques.

Main Methods:

  • Investigated thrombin-induced signaling in vascular smooth muscle cells.
  • Differentiated mechanisms of protein-tyrosine kinase receptor transactivation (matrix metalloproteinase signaling).
  • Identified the cytoskeletal rearrangement-Rho kinase-integrin system in serine/threonine kinase receptor transactivation.

Main Results:

  • Thrombin-mediated protein-tyrosine kinase receptor transactivation occurs via matrix metalloproteinase signaling.
  • Serine/threonine kinase receptor transactivation is mediated by a cytoskeletal rearrangement-Rho kinase-integrin pathway.
  • Both pathways concurrently drive proteoglycan synthesis stimulated by thrombin in vascular smooth muscle cells.

Conclusions:

  • Thrombin significantly stimulates proteoglycan synthesis in vascular smooth muscle cells through distinct kinase receptor transactivation pathways.
  • These findings provide crucial insights into the molecular mechanisms underlying thrombin's role in atherosclerosis.
  • The identified pathways represent potential therapeutic targets for mitigating plaque development and treating atherosclerosis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: